Group One Trading
HCAT icon

Group One Trading’s Health Catalyst HCAT Stock Holding History

Group One Trading’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02K Buy
+800
New +$1.5K ﹤0.01% 7212
2025
Q3 		– Sell
-2,000
Closed -$7.54K – 8683
2025
Q2 		$7.54K Hold
2,000
– – ﹤0.01% 6890
2025
Q1 		$9.06K Buy
+2,000
New +$10.6K ﹤0.01% 6329
2024
Q2 		– Sell
-2,200
Closed -$16.6K – 7032
2024
Q1 		$16.6K Buy
+2,200
New +$20.1K ﹤0.01% 5561
2022
Q4 		– Sell
-800
Closed -$8K – 7570
2022
Q3 		$8K Buy
+800
New +$10.6K ﹤0.01% 6627
2022
Q1 		– Sell
-100
Closed -$4K – 8278
2021
Q4 		$4K Hold
100
– – ﹤0.01% 7699
2021
Q3 		$5K Sell
100
-500
-83% -$27.3K ﹤0.01% 7732
2021
Q2 		$33K Buy
600
+100
+20% +$5.33K ﹤0.01% 6893
2021
Q1 		$23K Hold
500
– – ﹤0.01% 6701
2020
Q4 		$22K Buy
500
+300
+150% +$11.1K ﹤0.01% 5466
2020
Q3 		$7K Hold
200
– – ﹤0.01% 5532
2020
Q2 		$6K Buy
+200
New +$5.53K ﹤0.01% 5307

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's HCAT Position: Q1 2026 in Review

Group One Trading sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 86 shares — an estimated $162 sold.

Group One Trading first reported a position in HCAT in Q1 2020 and held it in 9 quarters. The position peaked at $116K in Q3 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Group One Trading reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 86 Health Catalyst shares in Q1 2026, an estimated $162.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and held it in 9 quarters.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.